Planmeca’s new intraoral scanner now available – Planmeca Onyx™ offers unforeseen flexibility for every clinic

Planmeca launched Onyx™, a new intraoral scanner for dental clinics featuring advanced optical technology, seamless data capture, and both wired and wireless operation. The product is now available for orders and was first unveiled at IDS 2025. The announcement is positive for Planmeca’s product pipeline, though likely limited in immediate market impact.

Analysis

This is a classic category feature update, but the second-order implication is distribution, not technology. A scanner that preserves precision while adding workflow flexibility should disproportionately matter to mid-market and multi-chair practices where chair-time utilization and staff turnover are bigger pain points than raw image quality. The likely winner set is the broader digital dentistry stack—especially CAD/CAM software, milling/material vendors, and practice-management ecosystems that can bundle hardware, consumables, and service contracts into a sticky installed base.

Competitive pressure should show up first on premium point-solution incumbents rather than on low-end devices. The real risk to rivals is not just unit share; it's attach rate compression as clinics standardize on a scanner that reduces switching costs between wired and wireless workflows. Over 6-18 months, that can slow replacement cycles for competitors and shift bargaining power toward the vendor with the best financing, onboarding, and support network, even if the hardware delta is modest.

The key tail risk is that this launch is more marketing than procurement-driven: dental clinics are capex-sensitive and tend to delay adoption until reimbursement, utilization, or training economics clearly justify it. If early reviews find the wireless workflow introduces downtime, battery degradation, or service complexity, adoption could stall within one ordering cycle. The setup becomes more meaningful if Planmeca can convert this into an ecosystem upgrade path rather than a standalone scanner sale.

Contrarian view: the market may be underestimating how quickly a 'good enough' scanner can commoditize a formerly high-margin niche. If precision differences are no longer decisive, value migrates to software integration, onboarding, and financing, which favors scaled platforms over specialized hardware brands. That means the most attractive trade may be against standalone scanner vendors with weak recurring revenue, not against the launch beneficiary itself.

Key Decisions for Investors

• Watch for weakness in standalone dental imaging/scanner names over the next 1-3 months; consider shorting high-multiple hardware-only names on any evidence of slower channel checks or elongated replacement cycles.
• Long the broader dental workflow enablers (pick-and-shovel angle) for 6-12 months, especially firms with software, consumables, or servicing revenue that benefit from higher scanner penetration and standardization.
• Pair trade: long integrated dental platform leaders / short pure-play scanner vendors to express a consolidation thesis; target a 10-15% spread if channel checks confirm bundling pressure.
• If you can source options, buy medium-dated puts on the weakest incumbent scanner franchise into the next product cycle review window; risk/reward improves if adoption is slower than the launch narrative implies.